NCCN Task Force Report: Bone Health In Cancer Care. Review uri icon

Overview

MeSH

  • Antineoplastic Agents, Hormonal
  • Bone Density
  • Calcium
  • Dietary Supplements
  • Humans
  • Risk Assessment
  • Vitamin D

MeSH Major

  • Bone and Bones
  • Neoadjuvant Therapy
  • Neoplasms
  • Osteoporosis

abstract

  • Bone health and maintenance of bone integrity are important components of comprehensive cancer care. Many patients with cancer are at risk for therapy-induced bone loss, with resultant osteoporotic fractures, or skeletal metastases, which may result in pathologic fractures, hypercalcemia, bone pain, and decline in motility and performance status. Effective screening and timely interventions are essential for reducing bone-related morbidity. Management of long-term bone health requires a broad knowledge base. A multidisciplinary health care team may be needed for optimal assessment and treatment of bone-related issues in patients with cancer. Since publication of the previous NCCN Task Force Report: Bone Health in Cancer Care in 2009, new data have emerged on bone health and treatment, prompting NCCN to convene this multidisciplinary task force to discuss the progress made in optimizing bone health in patients with cancer. In December 2012, the panel members provided didactic presentations on various topics, integrating expert judgment with a review of the key literature. This report summarizes issues surrounding bone health in cancer care presented and discussed during this NCCN Bone Health in Cancer Care Task Force meeting.

publication date

  • August 2013

has subject area

  • Antineoplastic Agents, Hormonal
  • Bone Density
  • Bone and Bones
  • Calcium
  • Dietary Supplements
  • Humans
  • Neoadjuvant Therapy
  • Neoplasms
  • Osteoporosis
  • Risk Assessment
  • Vitamin D

Research

keywords

  • Journal Article
  • Review

Identity

Language

  • eng

PubMed ID

  • 23997241

Additional Document Info

start page

  • S1

end page

  • 50; quiz S51

volume

  • 11 Suppl 3